We use cookies on this website to enhance your user experience. Please read our cookie policy for additional information and a complete overview. We will only use cookies if you consent by clicking on “Accept all cookies”. You can always manage your preferences via the settings of your browser. Please note that certain media will only be available if you have accepted the applicable cookies.
Epilog can de-risk and improve clinical trials
High quality data leads to better trial outcomes
EEG acquisitions are considered in the trial
- In the early stage of treatment development to evaluate the signal/effect
- As objective inclusion criteria and/or endpoints in a phase 2/3 study
- As biomarkers for your new treatment to target the further development and market access

Offering a total solution for the trial
- Ideation on the protocol together with sponsor, principle investigator, our internal experts
- Organizing high quality, standardized EEG recordings (in hospital or home setting)
- Central data collection and processing on fully secured, interactive data platform
- Unique hybrid model to process the validated EEG endpoints (automated plus central reader)


We couple our passion for EEG with high quality standards and focus on derisking your clinical trial.
- Project management, certification of centers, training, EEG charter, ...
- From objective seizure counting to more advanced sleep parameters
Examples of potential benefits in # phases of development
– Standardized reporting
– Data centralization
– Increased sensitivity to pick-up signals
– Standardized reporting
– Data centralization
– Control type of epilepsy for homogenous population
– Non-clinical seizures
– Responder / non-responder
– Standardized reporting
– Data centralization
– Ensure homogenous population
– Non-clinical seizures
– Patient stratification
– Standardized RWE
– Data centralization
– Impact on sleep
– Retrospective analysis
Our toolbox



